October 25, 2018
A New York federal judge has dismissed an investment fund's suit alleging a biopharmaceutical company violated a debt agreement by issuing fewer shares than owed, saying the parties' contract explicitly allows for the type of reverse stock-split that caused the supposed shortfall of shares.